In This Section

CICR Newsletter Archives​

Please note that, due to website constraints, the issues listed below may not contain all graphics and formatted content as in the original issuance. Additionally, certain links provided in the available content may not direct to the original information. Please excuse any inconvenience.

For questions, or for issues before February 2014, please email [email protected].

June 2020: New Drugs on the Horizon
February 2020: Targeted protein degradation

November 2019 : Kinase inhibitors
August 2019: Emerging druggable targets
May 2019: Antibody-drug conjugates
February 2019: Molecular imaging

November 2018: Nanomedicine
August 2018: Metabolic regulation of epigenetics
June 2018: Rational drug design
February 2018: Immunotherapy

November 2017: RAS: A challenging target
August 2017: The ubiquitin proteasome system
May 2017: Structure-based drug design
February 2017: Targeting transcription

November 2016: Targeted Drug Discovery
August 2016: The gamma-Glutamyl Cycle: an over-50 years controversy
May 2016: Cancer Metabolism
February 2016: Molecular Diagnostics

November 2015: Clinical Drug Formulation
August 2015: Exploiting protein-protein interactions for therapeutic intervention
June 2015: CICR at the AACR Annual Meeting 2015
February 2015: Personalized cancer treatments/ADCs

November 2014: Pancreatic Cancer Chemistry
August 2014: Biomarker Research
June 2014: CICR at the AACR Annual Meeting 2014
February 2014: Multidisciplinary cancer drug discovery